Background stories of how others approached and experienced their European Horizon funding trajectory.
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
Read the full article for detailsThe Marie Skłodowska-Curie Action (MSCA) European Innovative Training Network “PBNv2 - Next generation Pass-By Noise approaches for new powertrain vehicles” started in May 2017. Their research has the shared objective of investigating the possibilities to decrease pass-by noise of vehicles.
The project is a collaboration between 17 research institutions and companies in the European automotive R&D and provides a learning environment for 14 PhD fellows. The Belgian partner is the Noise and Vibration Research Group of KU Leuven, and this project is one of the many Horizon 2020 MSCA Innovative Training Networks that the KU Leuven research group participates in.